Nephros, Inc.
NEPH
$1.63
$0.00990.61%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -5.99% | -8.27% | -4.73% | 27.21% | 55.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.99% | -8.27% | -4.73% | 27.21% | 55.33% |
| Cost of Revenue | -11.56% | -8.59% | -15.83% | 17.54% | -6.01% |
| Gross Profit | -2.05% | -8.03% | 3.60% | 33.93% | 187.93% |
| SG&A Expenses | -19.47% | -13.31% | 0.85% | 34.92% | 22.60% |
| Depreciation & Amortization | -38.18% | -37.04% | -38.89% | -8.93% | 14.58% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.05% | -10.33% | -7.02% | 20.06% | 6.91% |
| Operating Income | 201.48% | 27.13% | 34.64% | 6.35% | 84.15% |
| Income Before Tax | 200.55% | 33.26% | 44.77% | 9.04% | 85.44% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 200.55% | 33.26% | 44.77% | 9.04% | 85.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 200.55% | 33.26% | 44.77% | 28.76% | 94.37% |
| EBIT | 201.48% | 27.13% | 34.64% | 6.35% | 84.15% |
| EBITDA | 262.59% | 26.18% | 34.13% | 6.27% | 87.55% |
| EPS Basic | 200.00% | 34.52% | 45.79% | 29.65% | 94.45% |
| Normalized Basic EPS | 199.08% | 34.60% | 45.70% | 19.42% | 87.21% |
| EPS Diluted | 187.00% | 34.52% | 33.33% | 47.03% | 93.62% |
| Normalized Diluted EPS | 199.08% | 34.60% | 45.70% | 19.42% | 87.21% |
| Average Basic Shares Outstanding | 0.80% | 2.06% | 1.98% | 1.29% | 1.52% |
| Average Diluted Shares Outstanding | 1.15% | 2.06% | 1.98% | 1.29% | 1.52% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
